Conatus Pharmaceuticals Inc. (CNAT)

[JeansOnFire]

http://stm.sciencemag.org/content/8/339/339ra69

https://www.nih.gov/news-events/news-releases/nih-collaboration-helps-advance-potential-zika-treatments

This shows how potent emricasan really is. And yet the market values it almost at 0/zero. That wont last for to long, no way jose. And lets not forget that cnat is the leader of pan-caspase inhibitors in the world, and surely have plenty more aces up their sleeves. They have the knowledge to perfect the formulation of future pan-caspase inhibitors. Future looks bright enough i would say.